K. Kogermann has been acting as a grant holder/principal investigator in several Estonian Science Foundation Projects. Her research interests include the physical pharmacy and solid state analysis-related as well as infection and antimicrobial therapy-related topics.
Her present research is focused on combining these two branches and develop antimicrobial nanofibrous matrices as controlled drug delivery systems for effective wound care (skin wounds and ora wounds) and investigation of their performance. In parallel with the preparation of the matrices novel testing methods are developed that enable to understand the performance and safety of the antimicrobial wound matrices.
The main goal is to understand the effects of the solid-state, mechanical and technological properties on the bioactivity of wound matrices. Hence the drug release, antimicrobial activity, and biofilm formation and antibiofilm studies are the main part of the study.
K. Kogermann is acting as an expert at the European Pharmacopoeia Commission Expert Group G12, and a member of Pharmacy Terminology Committee and Licencing Committee of the Estonian State Agency of Medicine. She is a past chairman and member of the Estonian Academical Society of Pharmacy and a founding member of Estonian Young Research Academy.